Nanjing Hicin Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 300584.SZ
Nanjing Hicin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -910.62 K
-
Nanjing Hicin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -4.35 M, a -84.15% change year over year.
-
Nanjing Hicin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -2.36 M, a 48.64% change year over year.
-
Nanjing Hicin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -4.60 M, a -33.36% change year over year.
-
Nanjing Hicin Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -3.45 M, a 1.94% change year over year.
| Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
|---|
Don’t Miss A Beat
| CEO | Mr. Yuping Cao |
| IPO Date | Jan. 12, 2017 |
| Location | China |
| Headquarters | No.1 Hengfa Road |
| Employees | 553 |
| Sector | Healthcare |
| Industries | |
Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
Past 5 years
StockViz Staff
February 4, 2025
Any question? Send us an email